349150-82-9

Upstream product

• 15258-72-7 2-chloro-6-nitrobenzyl chloride 
• 50608-25-8 N-(2-chloro-6-nitrobenzyl)glycine ethyl ester 

Downstream Products

• 85062-05-1 6-Chloro-1-phenyl-1,5-dihydro-imidazo[2,1-b]quinazolin-2-one; hydrochloride 
• 349150-96-5 [5-chloro-2,2-dioxo-1-(3-phenyl-propyl)-1,4-dihydro-2H-2λ⁶-benzo[1,2,6]thiadiazin-3-yl]-acetic acid ethyl ester 
• 349150-94-3 (1-benzyl-5-chloro-2,2-dioxo-1,4-dihydro-2H-2λ⁶-benzo[1,2,6]thiadiazin-3-yl)-acetic acid ethyl ester 

Relevant academic research and scientific papers

2-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2λ6-benzo [1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitors

Potent, selective, and structurally new inhibitors of the Fe(II) enzyme Escherichia coli peptide deformylase (PDF) were obtained by rational optimization of the weakly binding screening hit (5-chloro-2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-acetic acid hydra

1,5-Dihydroimidazoquinazolinones as blood platelet aggregation inhibitors

Syntheses of 1,5-dihydroimidazoquinazolinones and their activities as blood platelet aggregation inhibitors are described.

Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones

Optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]-quinazolin-2-ones and 6-[H]-1,2,3,4-tetrahydropyrimido[2,1-b]-quinazolin-2-ones or the pharmaceutically acceptable salts thereof are compounds useful as blood platelet anti-aggregative and/or antihypertensive and/or bronchodilator agents in mammals, including humans.